Timely Hydroxycut Legal Actions Have Recently Been Reported
On May 1, 2009, there had been a recall of 14 Hydroxycut diet-aid products springing from a number of reports that folks using the products were developing heavy liver problems and other health worries. Less than seven days later, on May 4, the 1st Hydroxycut class action lawsuit was filed against the company that manufactures the products, Iovate Medical Sciences. The Hydroxycut Lawsuit alleges company laxity in informing the public about potential risks of the products. Naturally, it’s too soon to know how the suit is going to turn out, but if the company had information which it didn’t divulge to buyers, it should definitely be held accountable.
A class action lawsuit is filed by a group of people, all of whom have similar claims against a certain company. Filing a class action is just as effective, and much less dear, than filing an individual suit. As a rule, filing a class action court action will not cost you anything unless there is a settlement. At that point, the attorney who handled the suit will take his fees from the compensation that was given and then distribute the leftover funds to the accusers in the case. Since this is the case, you’ll be ready to file a Hydroxycut class action suit without paying a penny out of your own pocket, which is one of the explanations that class action lawsuits have become so popular.
The 1st class action suit against Iovate was filed in Canada where the company is found and represents all Canadian citizens who sustained health problems due to Hydroxycut products. The FDA recall occurred in the United States where twenty-three cases of liver disorders and other health problems had been reported. Health Canada did not receive any reports of liver damage due to the diet products, but they did receive 17 reports concerning folks who sustained respiration, neurological, cardio, and stomach problems as a consequence of Canadians using the products.
The Hydroxycut Lawsuits alleges the company sold the company sold the products without properly informing the health hazards that they could exposing patrons to. The complaint states that the company failed to publish the information on the product labels stating that users could run the risk of liver and kidney damage as well as gastrointestinal, cardiovascular, respiratory, and neurological problems. The suit goes on to allege that this was a blatant omission on the part of the company which purposely misled clients concerning the security of the products.
